SCHEMBL13733673

SCHEMBL13733673

COC(=O)c1c(-c2cccc(F)c2)noc1N

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.72
RAB9A P51151 1/20 0.61
GAA P10253 3/20 0.54
TSHR P16473 2/20 0.54
MAPK1 P28482 1/20 0.54
PTGS1 P23219 2/20 0.51
GABRA5 P31644 4/20 0.49
GPBAR1 Q8TDU6 1/20 0.47
POLB P06746 1/20 0.42
DHODH Q02127 1/20 0.42
RPS6KB1 P23443 1/20 0.41
CSNK1D P48730 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
DYRK1A Q13627 1/20 0.41
NTRK2 Q16620 1/20 0.41
AURKB Q96GD4 1/20 0.41
ALDH1A1 P00352 1/20 0.41
JAK2 O60674 1/20 0.41
JAK3 P52333 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13734171 0.86 GPBAR1 (0.58) LMNAGAATSHRMAPK1PTGS1
SCHEMBL13732890 0.84 LMNA (0.60) LMNARAB9AGAATSHRMAPK1
SCHEMBL29161312 0.84 LMNA (1.00) LMNARAB9AGAATSHRMAPK1
SCHEMBL13733599 0.84 LMNA (0.49) LMNAGAATSHRGPBAR1DHODH
SCHEMBL12997955 0.84 LMNA (0.74) LMNARAB9AGAATSHRMAPK1
SCHEMBL13733820 0.83 LMNA (0.59) LMNARAB9AGAATSHRMAPK1
SCHEMBL28805575 0.77 GPBAR1 (0.44) LMNAGABRA5GPBAR1TP53HPGD
SCHEMBL13735711 0.76 LMNA (0.64) LMNARAB9AGAATSHRMAPK1
SCHEMBL23292547 0.76 LMNA (0.75) LMNARAB9AGAATSHRMAPK1
SCHEMBL13615438 0.75 HTT (0.54) LMNARAB9APTGS1GABRA5GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699566-B1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM CO LTD (KR) 2017-02-22 EP disclosed
US-9132126-B2 Phenyl-isoxazole derivatives and preparation process thereof IL-YANG PHARM. CO., LTD. (KR) 2015-09-15 US disclosed
EP-2699566-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF Il-Yang Pharm. Co., Ltd. (KR) 2014-02-26 EP disclosed
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2014-01-30 US disclosed
WO-2012144752-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF IL-YANG PHARM. CO., LTD. (KR) 2012-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140031364-A1 PHENYL-ISOXAZOL DERIVATIVES AND PREPARATION PROCESS THEREOF PIR, ALPL, PIGS LMNA 1031/4885RAB9A 3315/4885GAA 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.